Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Angioma, Cavernous

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Angioma, Cavernous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gueye, C; Laissy, JP; Scherrer, A; Somveille, E; Soyer, P1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Angioma, Cavernous

ArticleYear
MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    AJR. American journal of roentgenology, 1995, Volume: 165, Issue:6

    Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Chelating Agents; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Hemangioma, Cavernous; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric

1995